DNA-Guided heart drug choice may save lives in coronary artery disease

NCT ID NCT06665919

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study looked at whether using a person's genetic information to choose their blood-thinning medication (clopidogrel or an alternative) leads to better outcomes after a heart procedure. 283 adults with chronic coronary artery disease who had a stent placed were split into two groups: one received standard care, and the other had their treatment guided by a genetic test. The goal was to see if the genetic approach reduced deaths, heart attacks, and other heart-related events in real-world practice.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary โ€” we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder coronary artery disorder coronary thrombosis Death Hemorrhage hemorrhagic disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • 1st University Clinic of the Tbilisi State Medical University

    Tbilisi, Georgia

  • Cardio Expert Ltd., Clinic Cardio

    Tbilisi, Georgia

  • T. Oragvelidze Cardiology Center

    Tbilisi, Georgia

  • Tbilisi Institute of Medicine

    Tbilisi, Georgia